Hospitals and commercial companies are testing thousands of patients for COVID-19 daily, but face reagent and supply shortages.

Manufacturing sites are ramping up production of reagents needed to isolate SARS-CoV-2’s genetic material—a key step in testing for the virus.

Current methods to detect infections of the novel coronavirus rely on identifying particular genetic sequences, but new assays are being developed to meet the growing demand for rapid answers.

The scientific community said goodbye to Sydney Brenner, Paul Greengard, Patricia Bath, and a number of other leading researchers this year.

The Nobel laureate was a proponent of LSD, a consultant for O.J. Simpson’s legal defense, and the creator of a company that infused jewelry with celebrities’ DNA.

Researchers can now track the expansion of a resistance mechanism that allows the malaria vector Anopholes funestus to detoxify a key insecticide used on bed nets.

A heat block, a truck battery, and a novel RNA amplification assay make for in-the-field surveillance of the virus.

The US Food and Drug Administration gave emergency approval for a combination diagnostic that can distinguish between Zika, dengue, and chikungunya infections.

Scientists discover another species of Borrelia in the U.S.